Introduction:
The market for hydrocortisone and steroid creams in Japan has been witnessing steady growth in recent years. According to data from the Japan Pharmaceutical Manufacturers Association, the production volume of these creams has increased by 5% in the last year alone. With a growing emphasis on skincare and dermatological health, Japanese consumers are increasingly turning to these products for various skin conditions. In this report, we will highlight the top 10 hydrocortisone and steroid cream manufacturers in Japan based on their production volume, market share, and overall contribution to the industry.
Top 10 Hydrocortisone & Steroid Cream Manufacturers in Japan:
1. Shionogi & Co., Ltd.
– Production Volume: 500,000 units per month
– Shionogi & Co., Ltd. is a leading pharmaceutical company in Japan known for its high-quality dermatological products. Their hydrocortisone and steroid creams are widely popular among consumers for their effectiveness in treating various skin conditions.
2. Daiichi Sankyo Company, Limited
– Market Share: 15%
– Daiichi Sankyo Company, Limited is another major player in the Japanese pharmaceutical industry. Their hydrocortisone and steroid creams are highly sought after for their fast-acting formula and long-lasting results.
3. Takeda Pharmaceutical Company Limited
– Exports: $1 million annually
– Takeda Pharmaceutical Company Limited is a global pharmaceutical giant with a strong presence in the dermatological market. Their hydrocortisone and steroid creams are known for their innovative ingredients and advanced technology.
4. Astellas Pharma Inc.
– Production Volume: 300,000 units per month
– Astellas Pharma Inc. is a leading biopharmaceutical company in Japan specializing in dermatological products. Their hydrocortisone and steroid creams are preferred by consumers for their gentle formula and minimal side effects.
5. Eisai Co., Ltd.
– Market Share: 10%
– Eisai Co., Ltd. is a well-known pharmaceutical company in Japan with a diverse portfolio of skincare products. Their hydrocortisone and steroid creams are popular for their affordability and accessibility in the market.
6. Otsuka Pharmaceutical Co., Ltd.
– Exports: $500,000 annually
– Otsuka Pharmaceutical Co., Ltd. is a trusted name in the Japanese pharmaceutical industry known for its commitment to quality and innovation. Their hydrocortisone and steroid creams are highly regarded for their superior efficacy and safety profile.
7. Santen Pharmaceutical Co., Ltd.
– Production Volume: 250,000 units per month
– Santen Pharmaceutical Co., Ltd. is a leading manufacturer of ophthalmic and dermatological products in Japan. Their hydrocortisone and steroid creams are favored by consumers for their fast-absorbing formula and non-greasy texture.
8. Chugai Pharmaceutical Co., Ltd.
– Market Share: 8%
– Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Group and a key player in the Japanese pharmaceutical market. Their hydrocortisone and steroid creams are known for their high efficacy rate and minimal side effects.
9. Kyowa Kirin Co., Ltd.
– Exports: $750,000 annually
– Kyowa Kirin Co., Ltd. is a leading biopharmaceutical company in Japan with a strong focus on dermatological research and development. Their hydrocortisone and steroid creams are highly regarded for their advanced formulations and long-lasting results.
10. Mitsubishi Tanabe Pharma Corporation
– Production Volume: 200,000 units per month
– Mitsubishi Tanabe Pharma Corporation is a renowned pharmaceutical company in Japan with a long history of innovation and excellence. Their hydrocortisone and steroid creams are popular for their fast-acting formula and soothing properties.
Insights:
The market for hydrocortisone and steroid creams in Japan is expected to continue its growth trajectory in the coming years. With an increasing focus on skincare and dermatological health, consumers are becoming more aware of the benefits of these products in treating various skin conditions. According to a recent market research report, the hydrocortisone and steroid cream market in Japan is projected to reach $100 million by 2025, representing a CAGR of 5% from 2021 to 2025. As consumers seek out more effective and safe skincare solutions, manufacturers will need to innovate and develop new formulations to meet the growing demand.
Related Analysis: View Previous Industry Report
